This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Last week’s announcement that GE Healthcare would collaborate with Eli Lilly on a three-year project to develop in vitro diagnostics to predict the response of patients to targeted cancer therapies provides a glimpse of GE’s strategy for the diagnostics market.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.